{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "439",
                "469"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Zesp\u00f3\u0142 twarzowo-sk\u00f3rno-sercowy"
        },
        {
            "identifier": "T2",
            "position": [
                "474",
                "500"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Kardiomiopatia przerostowa"
        },
        {},
        {
            "identifier": "T3",
            "position": [
                "622",
                "630"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Metocard"
        },
        {
            "identifier": "T4",
            "position": [
                "632",
                "643"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Betaloc ZOK"
        },
        {
            "identifier": "T5",
            "position": [
                "645",
                "657"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "znieczulenie"
        },
        {
            "identifier": "T6",
            "position": [
                "661",
                "673"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "badania ECHO"
        },
        {
            "identifier": "T7",
            "position": [
                "783",
                "794"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Betaloc ZOK"
        },
        {
            "identifier": "T8",
            "position": [
                "795",
                "804"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "50mg 1xdz"
        },
        {
            "identifier": "T9",
            "position": [
                "943",
                "969"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "kardiomiopati\u0105 przerostow\u0105"
        },
        {
            "identifier": "T10",
            "position": [
                "1046",
                "1061"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan do\u015b\u0107 dobry"
        },
        {
            "icd": "ICD10:I42.2",
            "identifier": "N1",
            "referenced": "T2",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne kardiomiopatie przerostowe"
        },
        {
            "icd": "ICD10:I42.2",
            "identifier": "N2",
            "referenced": "T9",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne kardiomiopatie przerostowe"
        },
        {
            "arg1": "T7",
            "arg2": "T8",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 10 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Zesp\u00f3\u0142 twarzowo-sk\u00f3rno-sercowy.\\x0aKardiomiopatia przerostowa .\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nMetocard, Betaloc ZOK, znieczulenie do badania ECHO.\n------------------------------------------------\nZalecenia\n------------------------------------------------\nBetaloc ZOK 50mg 1xdz\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z kardiomiopati\u0105 przerostow\u0105 przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia krwi + PLT rozdzia\u0142 5 cz\u0119\u015b\u0107 WBC\n    WBC Krwinki bia\u0142e:7.05[10^3/ul]\n    RBC Krwinki czerwone:4.79[10^6/ul]\n    HGB Hemoglobina:13.1[g/dl]\n    HCT Hematokryt:36.3[%]\n    MCV wska\u017anik czerwonokrw:75.8[fl]\n    MCH wska\u017anik czerwonokrw:27.3[pg]\n    MCHC wska\u017anik czerwonokr:36.1[g/dl]\n    PLT z morfologii:308[10^3/ul]\n    RDW-SD:35.1[fl]\n    RDW-CV:13.0[%]\n    PDW:10.9[fl]\n    MPV:10.0[fl]\n    P-LCR:23.9[%]\n    PCT (hematokryt p\u0142ytkowy:0.31[%]\n    NEUTR# warto\u015b\u0107 bezwzgl\u0119d:3.65[10^3/ul]\n    NEUTR%:51.8[%]\n    LYMH# warto\u015b\u0107 bezwzgl\u0119dn:2.35[10^3/ul]\n    LYMPH%:33.3[%]\n    MONO# warto\u015b\u0107 bezwzgl\u0119dn:0.73[10^3/ul]\n    MONO%:10.4[%]\n    EO# warto\u015b\u0107 bezwzgl\u0119dna:0.25[10^3/ul]\n    EO%:3.5[%]\n    BASO# warto\u015b\u0107 bezwzgl\u0119dn:0.07[10^3/ul]\n    BASO%:1.0[%]\n    NRBC %:0.0[%]\n    NRBC #:0.00[10^3/ul]\nALAT: ALAT:13[U/L]\nASPAT: ASPAT:19[U/L]\nCK - aktywno\u015b\u0107: CK:34[U/L]\nCKMB aktywno\u015b\u0107: CKMB:18[U/L]\nCRP Bia\u0142ko C-reaktywne\n    CRP Bia\u0142ko C-reaktywne:\n    0.50[mg/dl]\nS\u00f3d (Na): S\u00f3d:142[mmol/L]\nPotas (K): Potas:4.1[mmol/L]\nMagnez: Magnez:0.81[mmol/L]\nMocznik: Mocznik:21[mg/dl]\nWap\u0144 ca\u0142kowity: Wap\u0144 ca\u0142kowity:2.32[mmol/L]\nProfil parametr\u00f3w krytycznych (ABL): pH:*\nNT-proBNP surowica: NT-proBNP w surowicy:50[pg/ml]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ28.3\nI42.2\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n------------------------------------------------"
}